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This article describes the history of melatonin's transformation, in the perception of the
biomedical community, from a skin-lightening agent in amphibians to a hormone in mammals,
which may also exert important behavioral-and physiological-effects in humans.
When Aaron Lerner and his colleagues discovered melatonin in 1958 [1], it is
unlikely that they anticipated that the medical significance oftheir work would derive
not from its role in their own medical discipline-dermatology-but from melatonin's
secretion as a hormone and its effects upon the brain. They quickly observed, probably
to their disappointment, that melatonin administration failed to constitute an effective
treatment for vitiligo, or even to reverse the hyperpigmentation that could be induced
by giving people the melanocyte-stimulating hormone. But, very soon thereafter,
investigators elsewhere were observing, in studies on laboratory animals, that mela-
tonin could affect the brain and, thereby, the gonads and other components of
neuroendocrine systems [2-4]. Two and a half decades later, evidence begins to
accumulate that melatonin may have important physiological and behavioral effects in
people and may even be involved in particular clinical syndromes or their treatments.
Only a few years before the discovery of melatonin, Mark Altschule and Julian
Kitay, at Harvard Medical School, had published a landmark monograph summariz-
ing the world's literature on the pineal gland [5]. Their main conclusion, that the pineal
somehow inhibits gonadal maturation and function, was supported by their own
laboratory finding that pinealectomy could accelerate gonadal growth in young rats,
and that administration of bovine pineal extracts had the opposite effect. These
findings were confirmed in our laboratory [6], supporting the hypothesis that the
pineal makes and contains a gonad-suppressing hormone. In 1960, Dr. Virginia Fiske,
ofWellesley College, hadjustdiscovered thatexposing a rat tocontinuous illumination
decreased the weight of its pineal gland [7]. Some years earlier, Fiske and other
zoologists had observed that continuous light exposure enlarged the gonads of
maturing rodents. Putting two and two together, it seemed possible that one function
(or even the function) of the mammalian pineal might be to mediate some of the
reproductive effects of environmental lighting: Perhaps the rate at which the pineal
secreted its hypothetical gonad-inhibiting hormone was decreased when animals were
placed under continuous illumination; if so, then the relative lack of this putative
inhibitor might underlie the gonadal hypertrophy. To examine this hypothesis, we
assessed the ability of bovine pineal extracts to block the gonadal hypertrophy and
abnormal estrous cycles induced in young rats by exposure to continuous light [8].
They worked: two and two indeed did make four. Now all we had to do was to discover
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the identity of the gonad-inhibiting substance in the mammalian pineal and see
whether its synthesis was suppressed when animals were exposed to environmental
lighting.
Work was begun on an additional, unrelated research problem, whose resolution
ultimately led to a collaboration with Dr. Julius Axelrod and a meeting with Dr.
Lerner. Infusions ofadrenaline were demonstrated to cause people to become anxious.
Since this result seemed a clear example of the body influencing the mind, an
experimental model was sought, perhaps akin to anxiety in humans, that could be used
to characterize the adrenaline effect. Dr. Peter Dews had shortly before conceived of
using Skinnerian conditioning techniques to explore problems in psychopharmacology:
pigeons or other animals were trained to depress a key for food, and rewarded either
after each n pecks or after the first peck following n minutes; they quickly learned
optimal strategies for getting the most food with the smallest number of movements.
Dews showed that these operant responses could be used to study effects of drugs on
behavior, different classes of drugs causing characteristic changes in behavioral
patterns. We showed that adrenaline did indeed have characteristic effects on
behavior, that these effects weredose-related, and that the dose-response curves varied
depending upon which isomer (d- vs. 1-form) was being used [9]. At about the same
time, however, Axelrod presented research showing that circulating adrenaline fails to
cross the blood-brain barrier [10]. (To this day it is not known why adrenaline
injections altered the behavior ofthe pigeons.) It seemed important to apply Axelrod's
neurochemical techniques, not only for studying the fate of epinephrine but also for
identifying the gonad-inhibiting hormone produced by the pineal gland.
At about this time, Axelrod himself was becoming interested in the methylating
enzymes [11], including those in the pineal gland, largely because of Dr. Lerner's
discovery of melatonin. Initially skeptical that there existed any enzyme in mammals
capable of forming melatonin (5-methoxy-N-acetyltryptamine) from its non-meth-
ylated precursor, Axelrod had gone on to discover the particular pineal enzyme
(HIOMT) that catalyzes this process [12]. We started in 1962 to work together on the
identity of the pineal hormone. Initially, we set up a bioassay for the compound in
pineal extracts, based on the observation that the extracts could keep the gonads from
hypertrophying, and block the estrous-cycle abnormalities among rats placed under
continuous illumination. We anticipated putting the pineal extracts through laborious
fractionation procedures and testing the gonad-inhibiting properties of each fraction.
But Axelrod proposed that we first see whether the one compound already known to be
characteristic ofthe pineal, melatonin, might also be a gonad inhibitor. We did, and it
was. Since melatonin was also known to be secreted from the pineal and taken up from
the bloodstream intovarious organs, this finding led us to propose that it was the pineal
gland's hormone [2].
If melatonin was the elusive pineal substance that inhibited the gonads, was its
synthesis or release also suppressed when animals were kept under continuous
illumination? We first attempted to find out using pineals from chickens: these were
relatively large and were readily available to us through a collaboration with a NASA
scientist, Dr. Charles Winget. No satisfactory assay was available for measuring tissue
melatonin levels, per se, so we had to assess melatonin synthesis indirectly, by
measuring the activity ofthe melatonin-forming enzyme, HIOMT, in pineal homoge-
nates, and hoping that nature would smile on our efforts by allowing the enzyme's
activity to vary in proportion with melatonin's actual rate of synthesis in vivo. (A
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decade had to pass before the development ofdirect assays for melatonin, which would
allow this assumption to be tested. Fortunately, once tested, pineal HIOMT activities
and melatonin levels were found to change in parallel after various light exposures.
This finding need not have been the case: it was just as likely that the methylation
reaction would have been controlled by substrate or cofactor levels as by the activity of
the enzyme.) Winget sent us pineals from birds exposed to light or dark for several
days; we assayed their HIOMT activities, and found that the changes in melatonin
formation were opposite to the way we had predicted, i.e., enzyme activity was higher
in organs from chickens exposed to light [13]. We learned that a more radioactive form
of ['4C]S-adenosylmethionine, the isotopically labeled cofactor used in the HIOMT
assay, had just become available, making it feasible to assay the enzyme in individual
pineals from rats. We repeated the light/dark study using rat organs, and found with
some relief that in this species light exposure suppressed pineal HIOMT activity, and
thus, in all likelihood, melatonin synthesis [14].
Early in 1963, soon after we obtained the initial evidence that melatonin might be
the gonad-inhibiting pineal hormone, Johannes Ariens-Kappers, a Dutch neuro-
anatomist, demonstrated that the major, and possibly sole, innervation of the rat's
pineal was by postganglionic sympathetic nerves originating in the superior cervical
ganglia. This suggested that the neuronal pathway through which light affected the
rat's pineal might also involve the same sympathetic nerves-a relationship confirmed
by removing the nerves and thereby terminating the pineal's response [15]. Similar
studies using enucleated animals, or rats with selective brain lesions, subsequently
showed that the photic input controlling melatonin synthesis enters the body through
the eyes, and then traverses a different CNS pathway, starting with the retino-
hypothalamic tract, from the pathways responsible for vision [15,16]. Pineal HIOMT
activities were also shown to exhibit a sympathetically mediated daily rhythm that
paralleled the 24-hour light/dark cycle. The assumption that the environmental cycle
generated the rhythm [17] was revised after Lynch and Ralph, using the first practical
melatonin assay, showed that the pineal melatonin rhythm persisted among animals
kept in continuous darkness, and thus was probably of endogenous origin, and
circadian, in the absence of a light/dark cycle [18].
By 1965 it was apparent that the mammalian pineal functions as a neuroendocrine
transducer, responding to nerve-type messages (norepinephrine released from its
sympathetic innervation) by releasing more ofa hormone (Aaron Lerner's melatonin);
moreover, it was clear that the pineal had a special role in converting an external cycle
(light/dark) into a "signal" that the brain could understand (that is, variations in
blood or CSF melatonin levels) and could use to modulate neuroendocrine functions in
rodents. This "melatonin theory" has remained the standard paradigm directing most
pineal research, subsequently buttressed by such observations as those showing that (a)
melatonin is an important mediator of photoperiodic changes in the hamster's testis
[19]; (b) the effectiveness of exogenous melatonin as an antigonadal agent varies
markedly depending on the time of its daily injection [20]; (c) norepinephrine
accelerates melatonin's synthesis from tryptophan in vitro [21], acting via beta
receptors and cyclic AMP [22]; (d) there are enormous daily swings in rat pineal
serotonin N-acetyltransferase activity [23]; (e) exogenous melatonin becomes concen-
trated within the midbrain and hypothalamus [24] and causes neurotransmitter
alterations in those brain regions [25]; (f) melatonin is antigonadal when placed in
these brain loci, but not elsewhere in the brain or in the pituitary [26]; and (g) a brain
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enzyme exists [27] which cleaves melatonin's indole nucleus and thereby generates
what may be the locally active forms ofthe hormone. It would not be difficult to double
the number ofitems in this list and still limit it to major innovations.
Probably the most compelling findings supporting the "melatonin theory" have been
those obtained in the last few years from studies on human subjects. Although the
earliest of these used bioassays of material extracted from body fluids (for example
[28], which demonstrated the early rhythm in human urinary melatonin), the general
exploration of pineal physiology in humans really awaited the development and
standardization of good radioimmunoassays [29]. These assays have now become
routine in tens of laboratories; other investigators routinely assay melatonin by mass
spectroscopy or high-pressure liquid chromatography. Until recently it appeared that
some of the physiologic rules governing the human pineal differed from those ofother
animals: exposing humans to continuous illumination seemed not to suppress the daily
nocturnal increase in melatonin secretion, at least over the short term. This apparent
difference, however, has been shown [30] to be an artefact of experimental design:
when humans are exposed at nighttime to light of ecologically adequate intensities
(i.e., a tenth or moreofthose normally present outofdoors on a cloudy day), melatonin
secretion is indeed suppressed.
The critical importance of an awareness of ecological factors in designing pineal
experiments now seems abundantly clear; this awareness makes it appear all the more
remarkable, in retrospect, that any of the original experiments on melatonin's actions
or secretion actually worked! These used a relatively insensitive species (albino rats
instead ofhamsters); the wrong light spectra (whatever happened to bearound, instead
of bulbs designed to simulate natural lighting); the wrong light intensities (animal
facilities lit for humans, not for rats); gave melatonin at the wrong times of day
(whenever it was convenient to do so); and, ofcourse, were based on hypotheses about
melatonin secretion derived from in vitro data about a single biosynthetic enzyme,
HIOMT. Perhaps a special angel watches over scientists working in far-out fields,
sometimes.
Administration ofexogenous melatonin to normal human subjects causes sleepiness
[31], and even-at the proper time of day-sleep [32]. Abnormalities in melatonin
secretion may also beinvolved-though theevidence isonly conjectural, at present-in
a behavioral disorder, the "Seasonal Affective Disorder Syndrome": such patients
(who exhibit severe depression in the fall or winter, with typical symptoms of
hypersomnia, weight gain, carbohydrate craving, and sadness [33]), often respond
favorably to "therapeutic" light intensities sufficient to suppress melatonin secretion.
The hypothesis that melatonin secretion has something to do with normal sexual
maturation in humans has recently been supported by the finding that the amplitudeof
the daily rhythm in plasma melatonin levels decreases by about 75 percent between
ages seven and 15 [34]. Nocturnal levels fall from about 200 to 50 picograms/ml;
daytime levels are low (5 picograms/ml) at all ages. Very large numbers ofinvestiga-
tors now seem to be working on finding roles in humans, or even therapeutic uses, for
Aaron Lerner's pineal hormone.
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